WHAT WE DO
WBB Securities is a leading investment management, investment banking, and equity research firm.  Established in 2001 and headquartered in San Diego, WBB Securities is a registered independent broker-dealer and investment advisor with proprietary trading desks that have market-making capabilities.  WBB Securities has built a nationwide team of respected senior investment and research professionals with a network of branches throughout the U.S. to serve institutional and high net worth clients.
 
The firm also maintains an investment banking and equity research practice focused exclusively in the life sciences niche.  Our investment bank has participated in over 120 transactions leading to $2 billion placed.  Whether raising capital or executing strategic transactions, our banking team is equipped to meet your financial needs and is comprised of some of the most knowledgeable people working in the life sciences domain.  Our firm has been distinguished from it peers for its equity research and analytics year after year for accuracy and performance by the financial industry's most highly regarded rankings organizations. 
 
OUR AREAS
INVESTMENT MANAGEMENT

Our Financial Advisors are skilled strategists and experts in financial planning, portfolio construction and investment management.

m&a AND STRATEGIC ADVISORY

We have the relationships and analytics in place to power your M&A needs through our strategic transactions unit.  

INVESTMENT BANKING

Our investment banking practice is focused in the field of life sciences and is comprised of a team of the best specialists in the field.  

institutional sales

Our sales and trading professionals can assist you to meet all of your institutional equity sales requirements.

equity research

We cover the most dynamic life sciences companies in the industry, and are continuously recognized for research performance.

EQUITY Capital Markets

We offer a full spectrum of innovative products and services to meet your capital needs.

PRESS RELEASES

VIEW ALL

WBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt Facility

NeoStem announces $20 million term loan financing from Oxford Finance LLC
CONTINUE READING

WBB Securities Sponsors BioCentury’s 21st Annual NewsMakers Conference

Executive Teams of Emerging Biotech Companies Present to Investor Community
CONTINUE READING

WBB Securities Acts as Co-manager to TetraLogic Pharmaceuticals on $47MM Convertible Senior Notes Transaction

WBB Securities acted as co-manager on a convertible senior notes transaction for TetraLogic Pharmaceuticals, Inc.
CONTINUE READING

OPINIONS & FEATURES

VIEW ALL

And The Winners Are Actavis, Allergan And Ackman

With White Knight Actavis standing in its corner, Allergan was able to outmaneuver Valeant Pharmaceuticals and Bill Ackman’s hedge fund,…
CONTINUE READING

Can Actavis Break The Siege Of Allergan?

The Allergan saga just became the stuff of George R.R. Martin novels.
CONTINUE READING

Does the GI Bill even work?

Over the last 12 months, failures in the VA healthcare system have dominated reporting about the Veterans Administration.
CONTINUE READING